Delivery Order 36F79721D0239-36C24522N0251
Award Date
1/12/22
Potential Completion Date
1/14/22
Potential Value
$31K
Federal Agency
Veterans Integrated Service Network 5
Awardee
Travere Therapeutics, Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92130, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5 awarded a $30,564.10 delivery order to Travere Therapeutics, Inc. for THIOLA 100 MG. The contract was issued against the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), has a firm fixed price, place of performance in San Diego, California, and completion date of September 26, 2022. No set-aside designation was used for this order to supply the drug THIOLA 100 MG in support of...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5 awarded a $28,380.95 delivery order to Travere Therapeutics, Inc. for THIOLA 100 MG. The contract was issued against the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), with a firm fixed price and no set-aside designation. Performance will take place in San Diego, California by April 1st, 2022. The delivery order was awarded to supply thiol drugs to support treatment programs...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5 awarded a $30,564.10 delivery order to Travere Therapeutics, Inc. for the pharmaceutical product THIOLA 100 MG. The contract was awarded on June 29, 2022 with a completion date of June 30, 2022. It utilizes the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) vehicle and has a firm fixed price. Performance will take place in San Diego, California. No set-aside designation was used...
This delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) was awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5 to Travere Therapeutics, Inc. for the delivery of THIOLA 100 MG tablets. Valued at $11,992.26, the firm fixed price contract has a period of performance through May 8, 2023 to supply the requested pharmaceutical product to support healthcare services for veterans in the San Diego,...
Travere Therapeutics, Inc. was awarded a $25,983.23 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5. The firm fixed price order, which has no set-aside designation, is for the delivery of 100 mg Thiola to the place of performance in San Diego, California. The order has a completion date of March 28, 2023 and was awarded on March 24, 2023 under Master GSA...
This is a firm fixed price delivery order awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 7 to Travere Therapeutics, Inc. for the supply of the pharmaceutical drug Thiola. The delivery order, valued at $124,160.04, was issued under Travere Therapeutics' Pharmaceuticals and Drugs GSA Schedule contract. Travere Therapeutics is a biopharmaceutical company that provides specialty pharmaceuticals to government agencies, including the...
The U.S. Department of Veterans Affairs (VA) has awarded a firm fixed price delivery order contract to Travere Therapeutics, Inc., a biopharmaceutical company that specializes in rare disease therapies. The contract, valued at $11,125.32, is for the supply of the pharmaceutical drug Thiola 100 mg. This delivery order is placed against Travere Therapeutics' Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract with the VA. Travere Therapeutics also holds a $25 million Blanket...
This is a firm fixed-price delivery order awarded by the U.S. Department of Veterans Affairs (VA) to Travere Therapeutics, Inc., a biopharmaceutical company specializing in rare disease therapies. The $31,521.74 contract is for the supply of Thiola 100 mg, a medication used to treat cystinuria. The award was made under Travere's Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB) with the VA. Travere also holds two $25 million Blanket Purchase Agreements (BPAs)...
This is a firm fixed-price delivery order awarded by the Department of Veterans Affairs (VA) to Travere Therapeutics, Inc., a biopharmaceutical company that specializes in developing and delivering therapies for rare diseases. The contract, valued at $87,515.28, is for the procurement of the drug tiopronin (Thiola) for the VA's pharmacy ordering requirements in fiscal year 2018. The contract was awarded under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and does not...
Travere Therapeutics, Inc. has been awarded a $11,125.32 firm fixed price delivery order from the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5 to supply Thiola 100 MG pharmaceutical products. The delivery order was issued under Travere's Pharmaceuticals and Drugs GSA Schedule contract (FSS-61-IB) with no set-aside applied, and performance will occur in San Diego, California by March 12, 2024. Travere specializes in developing therapies for...